Related Experiment Videos
Hepatic drug metabolism and immunostimulation
1Department of Pharmacology, Dalhousie University, Halifax, NS, Canada. ken.renton@dal.ca
Abstract:
When host defence mechanisms are stimulated there is a concomitant decrease in cytochrome P450 based drug biotransformation and elimination. This has resulted in a number of clinically important unwanted drug responses in patients with infections or inflammatory responses. The loss in cytochrome P450 is predominantly an effect at the level of the gene expression and the majority of enzyme forms examined to date are involved. Although the effect occurs predominantly in the liver it has been recently shown that inflammatory responses in the brain also cause a loss of the same enzyme forms in that organ. The loss of cytochrome P450 in the brain in response to localised inflammation is accompanied by a similar loss in the liver. The decrease of cytochrome P450 and its dependent drug biotransformation is of concern whenever drugs are used in patients with infections or disease states with an inflammatory component.
Insights
Host defense stimulation reduces cytochrome P450 (a key enzyme group) activity, impacting drug metabolism and potentially causing adverse drug reactions in patients with infections or inflammation.
Area of Science:
- Pharmacology
- Biochemistry
- Toxicology
Background:
- Host defense activation leads to decreased cytochrome P450 enzyme activity.
- This reduction impacts drug biotransformation and elimination.
- Clinically significant adverse drug responses have been observed in patients with infections or inflammation.
Purpose of the Study:
- To investigate the impact of stimulated host defense mechanisms on cytochrome P450 activity.
- To understand the implications for drug metabolism and patient safety.
Main Methods:
- Review of existing literature on cytochrome P450 gene expression and enzyme activity.
- Analysis of drug responses in patients with inflammatory conditions.
Main Results:
- Decreased cytochrome P450 activity is primarily due to reduced gene expression.
- Inflammatory responses in the brain also lead to a loss of cytochrome P450 enzymes, mirroring liver effects.
- This phenomenon affects multiple cytochrome P450 enzyme forms.
Conclusions:
- Reduced cytochrome P450 function during infection or inflammation poses a significant concern for drug therapy.
- Careful consideration of drug use is necessary in patients with inflammatory conditions to prevent adverse events.